Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer [Phase 2]
Sanofi’s Phase 2 trial of SAR240550 in combination with gemcitabine and cisplatin for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin [Phase 3]
Phase 3 trial comparing gemcitabine with cisplatin versus gemcitabine with carboplatin in non-small cell lung cancer reports hospitalization…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed [Phase 3]
Phase 3 trial update on combination chemotherapy for patients with surgically removed stage I to IIIA non-small cell lung cancer. The curren…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 study reports on the combination of celecoxib and erlotinib in patients with stage IIIB or stage IV non-small cell lung cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Paclitaxel and Carboplatin Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer That Cannot Be Removed During Surgery [Phase 3]
A Phase 3 trial compares paclitaxel plus carboplatin against standard chemotherapy for patients with unresectable stage III or stage IV non-…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 randomized trial comparing a three-drug regimen (vinorelbine, gemcitabine, and docetaxel) with a two-drug regimen (paclitaxel and ca…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer [Phase 1]
This clinical trial update covers a Phase 1 study evaluating hydroxyurea plus combination chemotherapy in patients with non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-09-16Clinical Trial Update: A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating BIIB022 in combination with paclitaxel and carboplatin in pa…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating azacitidine in patients with previously treated advanced non-small cell lung cancer; trial completed with …
-
CLINICAL_TRIALS trial_result · 2013-09-02Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the safety and tolerability of chemotherapy in combination with radiation therapy for non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) [Phase 2]
Phase 2 trial of cisplatin, docetaxel, and bevacizumab in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery [Phase 3]
Phase 3 trial evaluating dexamethasone with supportive care with or without whole-brain radiation therapy in patients with unresectable brai…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor [Phase 2]
A Phase 2 clinical trial evaluating sorafenib for non-small cell lung cancer after failure of EGFR tyrosine kinase inhibitors has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection [Phase 2]
Phase II study evaluating a regimen for stage IIIA non-small cell lung cancer. The trial uses induction therapy followed by surgical resecti…
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial update for albumin-bound paclitaxel (ABI-007) in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: Modafinil for the Treatment of Fatigue in Lung Cancer V9.0 [Phase 4]
A Phase 4 clinical trial evaluating modafinil for fatigue in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluating a multiple-vaccine therapy in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating a cancer antigen-targeting peptide vaccine combined with an anti-angiogenic peptide antigen in non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery [Phase 2]
Phase 2 trial update of vaccine therapy plus radiation therapy in patients with surgically resected non-small cell lung cancer. The study st…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC
Clinical trial update on the delivery and toxicity of adjuvant chemotherapy in patients with resected non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Effect of Exercise Training on Angiogenesis and Cachexia in Lung Cancer Patients [NA]
A completed clinical trial evaluated the impact of exercise training on angiogenesis and cachexia in patients with non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating a combination of paclitaxel, carboplatin, and gefitinib in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating mapatumumab in combination with paclitaxel and carboplatin in pati…
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating optimization of radiotherapy plus chemotherapy for advanced non-small cell lung cancer has completed.